A Dramatic Response To Antifungal Therapy In A Patient With Aerd

M. Lee,D. Corry,E. Li

DOI: https://doi.org/10.1016/j.anai.2024.08.766

2024-10-28

Abstract:Introduction Aspirin-exacerbated respiratory disease (AERD) is a condition characterized by the triad of asthma, nasal polyposis, and sensitivity to aspirin and other non-selective COX inhibitors. It remains an under-recognized entity that can be associated with significant morbidity. This case describes a dramatic response to antifungal therapy in a patient with AERD with concomitant airway mycosis. Case Description A 77-year-old male with AERD was referred to allergy clinic for persistent sinus problems. Prior therapies including oral and intranasal steroids, antibiotics, and multiple polypectomies were ineffective. CT of the sinuses showed complete opacification of all paranasal sinuses and bilateral nasal cavity polyposis. Initial sputum cultures were positive for hyphae and yeast. He was started on terbinafine 250mg daily. After three months of therapy he noted dramatic improvements in nasal congestion, facial fullness, and anosmia. Therapy was continued for another three months, after which his chronic sputum production completely resolved, along with a notable improvement in dyspnea. CT of the sinuses post-therapy showed complete resolution of prior pan-sinus disease. Discussion There is an emerging body of literature suggesting that airway mycosis leads to severe allergic airway diseases such as sinusitis, nasal polyps, and asthma. The utility of antifungal therapy specifically in patients with AERD remains unclear, and no reports have been published to date. This case illustrates the potential efficacy of antifungals in patients with AERD and culture-proven airway mycosis who do not respond to first-line therapies.

immunology,allergy